These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
701 related items for PubMed ID: 14707068
1. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. Wagner M, Poeck H, Jahrsdoerfer B, Rothenfusser S, Prell D, Bohle B, Tuma E, Giese T, Ellwart JW, Endres S, Hartmann G. J Immunol; 2004 Jan 15; 172(2):954-63. PubMed ID: 14707068 [Abstract] [Full Text] [Related]
3. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides. Gantner F, Hermann P, Nakashima K, Matsukawa S, Sakai K, Bacon KB. Eur J Immunol; 2003 Jun 15; 33(6):1576-85. PubMed ID: 12778475 [Abstract] [Full Text] [Related]
4. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses. Loré K, Betts MR, Brenchley JM, Kuruppu J, Khojasteh S, Perfetto S, Roederer M, Seder RA, Koup RA. J Immunol; 2003 Oct 15; 171(8):4320-8. PubMed ID: 14530357 [Abstract] [Full Text] [Related]
5. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. He B, Qiao X, Cerutti A. J Immunol; 2004 Oct 01; 173(7):4479-91. PubMed ID: 15383579 [Abstract] [Full Text] [Related]
7. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. Moseman EA, Liang X, Dawson AJ, Panoskaltsis-Mortari A, Krieg AM, Liu YJ, Blazar BR, Chen W. J Immunol; 2004 Oct 01; 173(7):4433-42. PubMed ID: 15383574 [Abstract] [Full Text] [Related]
9. B cells capturing antigen conjugated with CpG oligodeoxynucleotides induce Th1 cells by elaborating IL-12. Shirota H, Sano K, Hirasawa N, Terui T, Ohuchi K, Hattori T, Tamura G. J Immunol; 2002 Jul 15; 169(2):787-94. PubMed ID: 12097381 [Abstract] [Full Text] [Related]
10. Oligodeoxynucleotides containing CpG motifs induce low levels of TNF-alpha in human B lymphocytes: possible adjuvants for Th1 responses. Bohle B, Orel L, Kraft D, Ebner C. J Immunol; 2001 Mar 15; 166(6):3743-8. PubMed ID: 11238615 [Abstract] [Full Text] [Related]
11. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells. Decker T, Schneller F, Sparwasser T, Tretter T, Lipford GB, Wagner H, Peschel C. Blood; 2000 Feb 01; 95(3):999-1006. PubMed ID: 10648415 [Abstract] [Full Text] [Related]
12. Immunostimulatory CpG-DNA activates murine microglia. Dalpke AH, Schäfer MK, Frey M, Zimmermann S, Tebbe J, Weihe E, Heeg K. J Immunol; 2002 May 15; 168(10):4854-63. PubMed ID: 11994434 [Abstract] [Full Text] [Related]
13. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses. Pone EJ, Lou Z, Lam T, Greenberg ML, Wang R, Xu Z, Casali P. Autoimmunity; 2015 Feb 15; 48(1):1-12. PubMed ID: 25536171 [Abstract] [Full Text] [Related]
14. T cell-independent, TLR-induced IL-12p70 production in primary human monocytes. Bekeredjian-Ding I, Roth SI, Gilles S, Giese T, Ablasser A, Hornung V, Endres S, Hartmann G. J Immunol; 2006 Jun 15; 176(12):7438-46. PubMed ID: 16751389 [Abstract] [Full Text] [Related]
15. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production. McDyer JF, Li Z, John S, Yu X, Wu CY, Ragheb JA. J Immunol; 2002 Sep 01; 169(5):2736-46. PubMed ID: 12193748 [Abstract] [Full Text] [Related]
16. Rat plasmacytoid dendritic cells are an abundant subset of MHC class II+ CD4+CD11b-OX62- and type I IFN-producing cells that exhibit selective expression of Toll-like receptors 7 and 9 and strong responsiveness to CpG. Hubert FX, Voisine C, Louvet C, Heslan M, Josien R. J Immunol; 2004 Jun 15; 172(12):7485-94. PubMed ID: 15187127 [Abstract] [Full Text] [Related]
17. CpG-independent synergistic induction of beta-chemokines and a dendritic cell phenotype by orthophosphorothioate oligodeoxynucleotides and granulocyte-macrophage colony-stimulating factor in elutriated human primary monocytes. Wang J, Alvarez R, Roderiquez G, Guan E, Caldwell Q, Wang J, Phelan M, Norcross MA. J Immunol; 2005 May 15; 174(10):6113-21. PubMed ID: 15879106 [Abstract] [Full Text] [Related]
18. Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of toll-like receptor 9 but enhances responses to lipopolysaccharide in murine macrophages. Sweet MJ, Campbell CC, Sester DP, Xu D, McDonald RC, Stacey KJ, Hume DA, Liew FY. J Immunol; 2002 Jan 01; 168(1):392-9. PubMed ID: 11751985 [Abstract] [Full Text] [Related]
19. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity. Vollmer J, Weeratna RD, Jurk M, Davis HL, Schetter C, Wüllner M, Wader T, Liu M, Kritzler A, Krieg AM. J Leukoc Biol; 2004 Sep 01; 76(3):585-93. PubMed ID: 15218053 [Abstract] [Full Text] [Related]
20. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation. Datta N, Mukherjee S, Das L, Das PK. Eur J Immunol; 2003 Jun 01; 33(6):1508-18. PubMed ID: 12778468 [Abstract] [Full Text] [Related] Page: [Next] [New Search]